Transparency Market Research

Predictive Breast Cancer Gene Testing Market to Rise Due to Decreasing Costs of Treatment for Breast Cancer

Transparency Market Research Report Added "Predictive Breast Cancer Gene Testing Market" to its database.


Albany, NY -- (SBWIRE) -- 03/29/2016 -- A new market research report by Transparency Market Research, titled "Predictive Breast Cancer Gene Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019", presents an in-depth analysis of the market and helps in identifying the unmet needs within the market along with highlighting the attitude of physicians towards the present condition of gene testing.

The changes expected to take place in the predictive breast cancer gene testing market in the coming years owing to a number of swift technological developments have also been presented in this report. The report also evaluates the prevalent competition in the market along with providing an insightful review on the major industry drivers, challenges, trends, and restraints in the market. In addition, a competitor assessment comprising device sales forecasts and device approval evaluation has also been presented. The pipeline product profiles including clinical study details, efficiency, device approvals, safety, and device sales forecast also form an integral part of this study.

According to the report, factors such as decreasing costs of treatment for breast cancer and the rising access to tests involving breast cancer genes are amongst the major factors fuelling the market for predictive breast cancer gene testing. On the other hand, soaring initial costs for starting a new facility and the absence of standardization within genetic tests are amongst the chief factors inhibiting the growth of the market for predictive breast cancer gene testing. In addition, the rising complexities in the results of breast cancer gene tests and the absence of trained professionals have also posed a negative impact on the growth of the market, as per this study. In terms of end user, the market for predictive breast cancer gene testing is segmented into cancer hospitals, clinical laboratories, and research laboratories.

Download PDF:

In terms of geography, the report segments the market into Asia Pacific, North America, Europe, and Rest of the World (RoW). Amongst these, North America led the market for predictive breast cancer gene testing in 2013 with the company Myriad Genetics leading the market in the U.S. On the other hand, in Europe, the market is stimulated by the increasing funding via state governments. In addition, numerous private companies have also started their operations in Europe and hence are further augmenting the growth of the market in this region. The Asia Pacific predictive breast cancer gene testing market will also experience an exponential growth due to the rising growth in medical tourism within this region.

The report states that Myriad Genetics, Complete Genomics, Ambry Genetics, PreventionGenetics and Illumina are amongst the prime players operating in the predictive breast cancer gene testing market.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453